Recurrence rate according to patient characteristics and CTCs status.

NIAID Data Ecosystem2026-03-09 收录

数据链接：

https://figshare.com/articles/dataset/Recurrence_rate_according_to_patient_characteristics_and_CTCs_status_/3044473 数据链接链接失效反馈

官方服务：

资源简介：

Recurrence rate according to patient characteristics and CTCs status.

创建时间：

2016-10-26

Tissue microRNA signatures to predict breast cancer recurrence in young women aged under 35 years old

肿瘤复发预测

microRNA生物标志物

Identification for microRNA signatures to predict breast cancer recurrence in young women were performed through expression profiling of a total 2565 miRNAs in 45 samples diagnosed as invasive ducatal

NIAID Data Ecosystem80

Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Homo sapiens

肿瘤复发预测

基因表达谱分析

Lung cancer remains the leading cause of cancer death worldwide. Overall 5-year survival is about 10-15% and despite curative intent surgery, treatment failure is primarily due to recurrent disease. C

NIAID Data Ecosystem40

DNA methylation profiling of bulk tumors and sorted cells from colorectal cancer patients (Samsung Medical Center cohort)

肿瘤复发预测

甲基化组学

To identify biomarkers for predicting recurrence of colorectal cancer patients, we performed targeted bisulfite sequencing for (1) isolated cell types in blood and tumors from 7 patients and (2) bulk

NIAID Data Ecosystem30

Molecular Determinants of Post-Mastectomy Breast Cancer Recurrence

肿瘤复发预测

MAPK信号通路突变

Breast cancer (BC) adjuvant therapy after mastectomy in the setting of 1-3 positive lymph nodes has been controversial. This retrospective Translational Breast Cancer Research Consortium study evaluat

NIAID Data Ecosystem40

Increase of blood CSF3R+ myeloid-derived suppressor cell predicts breast cancer recurrence [Immune]. Increase of blood CSF3R+ myeloid-derived suppressor cell predicts breast cancer recurrence [Immune]

肿瘤免疫微环境

肿瘤复发预测

Early detection of recurrence by using specific biomarkers is still a clinically unmet need although methodologies for monitoring tumor markers, cell-free DNA and circulating tumor cells have been est

NIAID Data Ecosystem30

Recurrence rate according to patient characteristics and CTCs status.

资源简介：

相关数据集